We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTCT icon
101
PTC Therapeutics
PTCT
$6.37B
$17.4M 0.22%
462,523
+60,000
+15% +$2.01M
FTV icon
102
Fortive
FTV
$19B
$17.1M 0.22%
323,001
+271,801
+531% +$13.2M
PCAR icon
103
PACCAR
PCAR
$69.6B
$17.1M 0.22%
376,133
-42,124
-10% -$1.83M
EXEL icon
104
Exelixis
EXEL
$13.9B
$17M 0.22%
713,142
+165,182
+30% +$3.77M
PFE icon
105
Pfizer
PFE
$140B
$16.9M 0.22%
420,520
-58,047
-12% -$2.32M
NOAH
106
Noah Holdings
NOAH
$588M
$16.6M 0.21%
+343,000
New +$16.6M
EOG icon
107
EOG Resources
EOG
$78B
$16.5M 0.21%
173,449
+121,317
+233% +$11.6M
VRNS icon
108
Varonis Systems
VRNS
$5.25B
$16.3M 0.21%
821,256
+286,134
+53% +$5.43M
DFS
109
DELISTED
Discover Financial Services
DFS
$16.2M 0.21%
228,079
-13,760
-6% -$942K
BAC icon
110
Bank of America
BAC
$435B
$16.2M 0.21%
586,297
-41,807
-7% -$1.18M
EL icon
111
Estee Lauder
EL
$29B
$16.1M 0.21%
97,347
-88,676
-48% -$13M
USG
112
DELISTED
Usg
USG
$16.1M 0.21%
371,000
+271,000
+271% +$11.7M
DAL icon
113
Delta Air Lines
DAL
$55.9B
$16M 0.2%
309,644
+280,102
+948% +$13.9M
KYNB
114
Kyntra Bio
KYNB
$28.5M
$15.8M 0.2%
11,636
-2,400
-17% -$3.25M
HOLI
115
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$15.5M 0.2%
742,244
+290,645
+64% +$5.98M
NFLX icon
116
Netflix
NFLX
$292B
$15.5M 0.2%
433,640
+17,020
+4% +$590K
CI icon
117
Cigna
CI
$76.6B
$15M 0.19%
93,017
-26,704
-22% -$4.88M
SLAB icon
118
Silicon Laboratories
SLAB
$7.15B
$14.9M 0.19%
184,118
+71,471
+63% +$5.94M
LH icon
119
Labcorp
LH
$24.3B
$14.8M 0.19%
112,853
+84,976
+305% +$10.5M
CL icon
120
Colgate-Palmolive
CL
$72.6B
$14.6M 0.19%
200,326
-59,168
-23% -$3.82M
COP icon
121
ConocoPhillips
COP
$147B
$14.6M 0.19%
218,480
-34,008
-13% -$2.29M
MDLZ icon
122
Mondelez International
MDLZ
$77.7B
$14.5M 0.19%
242,427
+79,319
+49% +$3.64M
NKTR icon
123
Nektar Therapeutics
NKTR
$2.39B
$14.4M 0.18%
28,586
-1,161
-4% -$688K
HRTX icon
124
Heron Therapeutics
HRTX
$86.3M
$14.4M 0.18%
588,600
+125,000
+27% +$3.27M
BEN icon
125
Franklin Resources
BEN
$16.9B
$14.4M 0.18%
433,621
-54,635
-11% -$1.73M
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.